This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The looming threat is the pending patentapplications by Gilead in India. A Look at the Pre-Grant Oppositions Gilead has multiple patentapplications for Lenacapavir in India, including those seeking patents on its choline and sodium salts. and the oppositions raised against these applications.
Madras HC Remands PatentApplication Back to IPO for Reconsideration By Md. Sabeeh Ahmad The Madras HC in a judgment this week has, on an appeal by Hendrickson USA (manufacturers of heavy-duty suspensions), remanded their patentapplication for “Axle Mount For Heavy-Duty Vehicle Brake System Components” back to the Patent Office.
In 2015, the US linked its design patent system with Hague — this gives U.S. applicants easier access to the U.S. design patents originated from outside of the U.S.; with Chinese-origin design patents taking the clear quantitative lead over all other nations. by Dennis Crouch.
PatentApplication No. PatentApplication No. 14/685,504, filed April 7, 2015, or U.S. PatentApplication No. On June 11th, Junior Party the University of California, Berkeley; the University of Vienna; and Emmanuelle Charpentier (collectively, "CVC") filed its Responsive Preliminary Motion No.
PatentApplication No. PatentApplication No. 14/685,504, filed April 7, 2015, or U.S. PatentApplication No. On June 11th, Junior Party the University of California, Berkeley; the University of Vienna; and Emmanuelle Charpentier (collectively, "CVC") filed its Responsive Preliminary Motion No.
Legal Background: Grace Periods According to Article 54 EPC , the state of the art for determining novelty constitutes everything that was made available to the public before the priority date of the patentapplication, regardless of whether the applicant/inventor was responsible for the publication. 102(b)(1)(A) ).
In a precedential opinion issued on March 6, the Federal Circuit affirmed the US District Court for the Eastern District of Virginia that the claims in ImmunoGens US patentapplication 14/509,809 (the 809 application, published on May 14, 2015, as US 2015/0132323) were obvious. By: ArentFox Schiff
Reddy’s case, a revocation application was filed under Section 64 against a patent granted in favour of Boehringer Ingelheim International GmbH. Boehringer’s patentapplication was filed in 2006 and granted in 2015 by the Delhi Patent Office, against which Dr. Reddy’s filed a revocation petition in 2021 in the Delhi High Court.
In 2014, UCB sued Actavis for infringement of the Muller patents. UCB prevailed in the lawsuit, and was awarded an injunction against Actavis until March 2021, when one of the Muller patents expires. In 2018, UCB filed a new patentapplication (the “’589 patent”, priority date 2009) covering a reformulation of Neupro.
November 4, 2022: The Madras High Court allowed the two writ petitions filed by the applicant with respect to two patentapplications that were deemed abandoned by the Indian Patent Office on account of delay in filing the Request for Examination. In Chandra Sekar Vs. The Controller of Patents and Designs & Anr.
by Dennis Crouch In recent years, the United States Patent and Trademark Office (USPTO) has undergone a significant shift in its examiner composition, with real implications for patent prosecution strategies. Prior to 2015, over 35% of patents were examined by assistant examiners. Here’s why: 1.
The two studies found that firms that file for patentapplications are disproportionately more often owned by men. They also found that women-owned businesses are less likely to have their applications for funding granted (54.8%) as compared to their male counterparts (56.1%).
This is perhaps not surprising, given that patentapplications are not published until 18 months after they are filed, and that OpenAI's major innovation of ChatGPT was first released about 2 years ago. This year, eleven OpenAI patents and patentapplications have been published. Who are OpenAI?
Services like All Prior Art are using AI to churn out and ‘publish’ many millions of generated texts, hoping some will preempt future patentapplications. Ben Hattenbach & Joshua Glucoft have an interesting 2015 article on point. Patents in an Era of Infinite Monkeys and Artificial Intelligence , 19 Stan.
Highlights of the Week Delhi High Court Stirs the Pot for Biotech PatentApplicants in India On the recent Delhi High Court judgement concerning a genetically modified salmonella bacteria, Prashant Reddy explains how the Court erred by applying Section 3 on a microorganism and incorrectly applied the disclosure requirement under Section 10.
In our new paper, The Truth About Design Patents , we debunk three widely held—but incorrect—views about U.S. design patents. Taken together, these myths paint a grim picture of design patents: Half of all design patentapplications are rejected. Most asserted design patents are invalidated in litigation.
Lee is vice president at Amazon Web Services and was the Undersecretary of Commerce and Director of the United States Patent and Trademark Office (2015-2017). She spent a decade at Google leading their patent team. . In 2015, I became Director of the USPTO, and the AIA changes had been in place for barely a few years.
In 2009, Dr. Robinson and Spectrum (collectively “Plaintiffs”) hired law firm FisherBroyles to file patentapplications for his inventions. patentapplication for the spinal implant in March 2013. It then filed a PCT application and a non-provisional U.S. application in March 2014 that issued in 2018.
Macleod, refused to put their names on the patent for the drug, with Banting stating “as a physician who had taken the Hippocratic oath he could not be party to any patenting of a discovery.” Thus, the first patentapplication for an insulin patent was filed under Best and Collip’s names.
However, this Australian study better reflects worldwide applications because most Australian patentapplications are from international inventors who have filed patents in several jurisdictions. The study revealed that male sounding names were much more likely to have their patents granted.
The case arises out of a 2018 lawsuit, in which four self-described inventors of DNA Arrays brought suit against Illumina, a “multibillion-dollar, global player in genetic analysis,” alleging that Illumina and its associates conspired to steal Petitioner’s trade secrets and covertly conceal the information in patentapplications.
Under the European Patent Convention (EPC) and national patent regulations in the countries that adhere to the Convention, which include Spain, an invention is patentable if it fulfills, among other requirements, the inventive step requirement ( article 54(1), (2) EPC and article 4(1) of Patents Law 24/2015 ).
Prior Patently-O coverage of this appeal is available here.) My 2015 article, The Patented Design , was mentioned several times during the argument. In that article, I argued that a design patent’s scope should be limited to the design as applied to a specific type of product. 161, 219–20 (2015) (footnotes omitted).
Patent and Trademark Office claims that the agency's pro bono program has provided "over $39.3 million in donated legal services" since 2015 and noted on Tuesday that those free services have also seen "high participation rates" by female patentapplicants.
The PTO responsive brief is due December 14, 2023. = = = The Federal Circuit recently affirmed a PTAB rejecting claims in a patentapplication filed by Institut Pasteur on the ground of obviousness-type double patenting. The policy goal is to prevent unjustified timewise extension of exclusive patent rights.
The functional format also simplifies claim drafting for complex inventions and supports filing patents amidst technological uncertainty before landing on a final design. As MPF claims were declining, patentapplicants still felt the draw for functional limitations and began to use alternative claiming strategies. 3d 1339 (Fed.
Matthews, §4 Annotated Patent Digest § 25:76 (“Surrender arises from a patentee’s canceling or amending a claim to avoid a prior art rejection and relying on the amended matter as avoiding the prior art.”). Schor, The Reissue Recapture Doctrine: Its Place Among the Patent Laws , 22 Cardozo Arts & Ent.
In this era, 7% of all patents were from the medical innovation sector. c) For the next 35 years till 2000, Computer and related innovation (“ ICTs ”) tripled and the sector represented 24% of all patents and showed an 8% annual growth rate.
The Manual of Patent Examining Procedure (MPEP) 608.01(p) Failure to do so raises an inequitable conduct issue related to the applicant’s duty of disclosure, as discussed in our related posts here and here. In fact, a patentapplication does not need to provide a guarantee that a prophetic example actually works!
Legal Background: Duty of disclosure and inequitable conduct Patentapplicants and attorneys prosecuting patentapplications at the USPTO have a duty to disclose information that is material to the patentability of the intention ( 37 C.F.R. As such, the patentapplication indicated, a formulation of pH of 2.8-3.3
13.5) (T 919/15, T 536/07, T 1437/07, T 266/10, T 863/12, T 184/16, T 2015/20). In other words, according to this case law, post-published evidence should be taken into account if the purported technical effect is not implausible (r. The test is whether there was substantiated doubt at the filing date.
The program initially began in 2015 to accelerate examination by combining the search expertise of examiners at the USPTO and the JPO, providing more comprehensive prior art searches to PatentApplicants. PatentApplicants should benefit from the program due to the increased collaboration with the Japanese Patent Office.
The Patent Pro Bono Program is a nationwide network that matches volunteer patent professionals with financially under-resourced inventors and small businesses for the purpose of securing patent protection. Since its launch in 2015, more than 1,800 patent professionals have volunteered their time and resources to the program.
Here is our recap of last week’s top IP developments including summary of the posts on the Lenacapavir patentapplication and oppositions, ANRF and corporatisation of research, the copyright dispute between Jasleen Royal and T Series, and DHC’s recent order in Master Arnesh Shaw v. Anything we are missing out on?
This is a case that has been vigorously litigated since 2015 and has already been up on appeal to the U.S. CODA and its owner, Frantisek Hrabel, brought suit against Goodyear and one of its engineers, Robert Benedict, in 2015, claiming that Benedict and Goodyear had stolen their trade secrets for a self-inflating tire technology and process.
This is a case that has been vigorously litigated since 2015 and has already been up on appeal to the U.S. CODA and its owner, Frantisek Hrabel, brought suit against Goodyear and one of its engineers, Robert Benedict, in 2015, claiming that Benedict and Goodyear had stolen their trade secrets for a self-inflating tire technology and process.
important;}} The United States Patent and Trademark Office (USPTO) grants hundreds of new patents every week, showcasing developments in technology and innovation. In our Interesting Patents series, we highlight exciting US patentapplications and patents recently issued by the USPTO.
I will also note here that there are a number of pre-GATT cases that do apply OTDP using later-filed applications as a reference, but that was a different time when patent term was measured from the issue date. 1530 (2015) and distinguished the issue-date focus of the classic Supreme Court case of Miller v. Natco Pharma Ltd. ,
While there is a high prevalence of generic alternatives, the agrochemicals industry in India is observing an increase in the number of patentapplications filed. The White Paper analysed the ‘working’ of patented pesticides in India for patents expiring between 2015 and 2022. Brief Findings of the Study.
The lawsuit was filed in July of 2015 and asserted two patents: U.S. Patent Nos. 8,191,091 and 8,559,635 (the “’635 Patent”) (collectively the “Asserted Patents”). In February 2017, Apple filed inter partes review of the Asserted Patents. The Procedural History and Facts of the Case.
This is why it is important to be able to justify the registration of the patent in another territory, if it is not initially registered in Spain. However, following the entry into force of Patents Law 24/2015 (PL), we need to reassess whether this is always the best strategy. Compulsory application for protection in Spain.
Determining inventorship, prior to patent issuance, can save an applicant the costly procedural and evidentiary burden required for correcting the named inventors post patent issuance. The test asks two questions: 1. Does it appear that one or more of the named inventors have no part in the invention?
Analysing this decision, first of all, the question arises as to how it was possible to register this patent? The subject matter of the patented invention must be new at the time of filing a patentapplication.
Underscoring the irony, he observed that some of the patents TKDL opposed in the U.S. and Europe were also filed in India and may proceed to grant—since TKDL doesn’t offer the same services to the Indian Patent Office as it does to the USPTO and EPO. Basheer’s Middle Path Solution to Drug Patent Linkage Controversy.
We organize all of the trending information in your field so you don't have to. Join 9,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content